Your Advocates Ltd’s ARK Genomic Revolution ETF ARKG Stock Holding History

Your Advocates Ltd’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10	Closed	-$278	–	241
2025 Q3	$278	Hold	10	–	–	﹤0.01%	200
2025 Q2	$244	Hold	10	–	–	﹤0.01%	187
2025 Q1	$208	Hold	10	–	–	﹤0.01%	194
2024 Q4	$236	Hold	10	–	–	﹤0.01%	193
2024 Q3	$256	Hold	10	–	–	﹤0.01%	211
2024 Q2	$235	Hold	10	–	–	﹤0.01%	216
2024 Q1	$288	Hold	10	–	–	﹤0.01%	209
2023 Q4	$328	Hold	10	–	–	﹤0.01%	217
2023 Q3	$279	Hold	10	–	–	﹤0.01%	260
2023 Q2	$341	Hold	10	–	–	﹤0.01%	259
2023 Q1	$301	Hold	10	–	–	﹤0.01%	225
2022 Q4	$282	Hold	10	–	–	﹤0.01%	209
2022 Q3	$0	Sell	10 -20	-67%	-$734	﹤0.01%	199
2022 Q2	$1K	Sell	30 -20	-40%	-$699	﹤0.01%	176
2022 Q1	$2K	Sell	50 -10	-17%	-$477	﹤0.01%	171
2021 Q4	$4K	Sell	60 -20	-25%	-$1.38K	﹤0.01%	127
2021 Q3	$6K	Buy	+80	New	+$6.71K	﹤0.01%	109

Other funds holding ARKG

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Your Advocates Ltd's ARKG Position: Q4 2025 in Review

Your Advocates Ltd sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2025, closing a stake of 10 shares — an estimated $278 sold.

Your Advocates Ltd first reported a position in ARKG in Q3 2021 and held it in 17 quarters. The position peaked at $6K in Q3 2021. 239 funds tracked by Wall St. Rank hold ARKG as of Q4 2025.

Your Advocates Ltd reported no remaining ARK Genomic Revolution ETF position as of Q4 2025 after selling out during the quarter.
Your Advocates Ltd sold 10 ARK Genomic Revolution ETF shares in Q4 2025, an estimated $278.
Your Advocates Ltd first reported a position in ARK Genomic Revolution ETF in Q3 2021 and held it in 17 quarters.
Your Advocates Ltd's ARK Genomic Revolution ETF position peaked at $6K in Q3 2021.
239 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2025.

Based on Your Advocates Ltd's 13F filing for Q4 2025, filed 2 Feb 2026.